IL1RL2 and intestinal disorder: The anti-inflammatory ability of IL-36Ra is increasingly recognised and recently demonstrated in psoriasis and rheumatoid arthritis, with neutrophil reduction also noted in intestinal disease in IL-36R knock-out mice (40).